First Header Logo Second Header Logo

Stephen Peters

Concepts (534)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Asthma
142
2021
438
17.580
Why?
Anti-Asthmatic Agents
32
2018
72
4.520
Why?
Bronchodilator Agents
33
2021
89
4.260
Why?
Pulmonary Disease, Chronic Obstructive
22
2021
142
3.330
Why?
Adrenal Cortex Hormones
37
2021
163
3.320
Why?
Adrenergic beta-Agonists
20
2014
53
2.390
Why?
Lung
21
2020
262
2.220
Why?
Albuterol
19
2018
40
1.980
Why?
Eosinophils
12
2019
55
1.710
Why?
Humans
177
2021
32297
1.630
Why?
Glucocorticoids
14
2020
161
1.600
Why?
Sputum
12
2020
43
1.400
Why?
Administration, Inhalation
37
2020
94
1.380
Why?
Scopolamine Derivatives
4
2013
9
1.380
Why?
Budesonide
7
2016
11
1.370
Why?
Adult
98
2021
9467
1.340
Why?
Receptors, Adrenergic, beta-2
11
2019
36
1.260
Why?
Female
118
2021
20126
1.260
Why?
Forced Expiratory Volume
39
2021
126
1.220
Why?
Male
115
2021
19488
1.200
Why?
Severity of Illness Index
28
2021
926
1.140
Why?
Immunotherapy
2
2017
83
1.130
Why?
Middle Aged
79
2021
11949
1.100
Why?
Respiratory Function Tests
25
2021
122
1.000
Why?
Phenotype
26
2020
656
0.940
Why?
Polymorphism, Single Nucleotide
24
2019
1092
0.910
Why?
Bronchi
9
2021
45
0.890
Why?
Adolescent
42
2019
3571
0.830
Why?
Polymorphism, Genetic
7
2020
194
0.830
Why?
Double-Blind Method
23
2019
550
0.810
Why?
Ethanolamines
5
2010
16
0.810
Why?
Bronchial Provocation Tests
6
2011
14
0.760
Why?
Pulmonary Emphysema
4
2021
14
0.720
Why?
Leukotriene Antagonists
6
2016
8
0.710
Why?
Disease Progression
12
2020
618
0.710
Why?
Child
31
2019
2472
0.700
Why?
Genetic Predisposition to Disease
9
2019
849
0.670
Why?
Antibodies, Monoclonal
4
2017
250
0.640
Why?
Biological Therapy
2
2017
22
0.620
Why?
Aged
37
2021
10398
0.610
Why?
Anti-Allergic Agents
1
2017
7
0.610
Why?
Smoking
6
2021
493
0.610
Why?
Immune System Diseases
1
2017
2
0.600
Why?
Nasal Polyps
1
2017
3
0.590
Why?
Dyspnea
3
2013
34
0.580
Why?
European Continental Ancestry Group
10
2020
1180
0.580
Why?
Neutrophils
5
2017
118
0.570
Why?
Genome-Wide Association Study
12
2019
560
0.560
Why?
Young Adult
26
2020
2626
0.550
Why?
Pharmacogenetics
7
2015
36
0.530
Why?
Inflammation
10
2020
542
0.530
Why?
Drug Therapy, Combination
10
2019
301
0.530
Why?
Acetates
5
2017
15
0.520
Why?
Quinolines
5
2017
28
0.520
Why?
Nebulizers and Vaporizers
3
2017
14
0.510
Why?
Cell Adhesion Molecules
2
2006
47
0.490
Why?
Phosphoproteins
2
2006
55
0.480
Why?
Spirometry
9
2019
36
0.470
Why?
Hypersensitivity, Immediate
3
2020
10
0.460
Why?
Cholinergic Antagonists
2
2010
12
0.450
Why?
Th2 Cells
5
2020
15
0.450
Why?
Cytokines
5
2020
262
0.440
Why?
Eosinophilia
3
2018
15
0.440
Why?
Collagen Type III
2
2003
13
0.430
Why?
Leukocyte Count
8
2019
64
0.430
Why?
Treatment Outcome
22
2021
3358
0.430
Why?
African Americans
9
2020
1443
0.420
Why?
Respiratory Tract Infections
3
2018
42
0.420
Why?
Internet
3
2017
203
0.410
Why?
Cholecalciferol
3
2018
23
0.410
Why?
Obesity
7
2021
1164
0.410
Why?
Fibroblasts
2
2003
118
0.400
Why?
Muscle, Smooth
4
2005
74
0.400
Why?
Airway Obstruction
5
2019
32
0.400
Why?
Vital Capacity
9
2021
53
0.390
Why?
Epithelial Cells
2
2003
149
0.390
Why?
Bronchoscopy
6
2017
57
0.390
Why?
Sex Factors
7
2018
674
0.380
Why?
Adenocarcinoma, Papillary
1
2010
3
0.370
Why?
Choristoma
1
2010
18
0.370
Why?
United States
17
2019
3983
0.360
Why?
Intra-Abdominal Fat
1
2010
66
0.360
Why?
Health Surveys
2
2009
202
0.360
Why?
Nitric Oxide
9
2020
121
0.360
Why?
Pancreas
1
2010
104
0.350
Why?
Occupational Exposure
2
2018
238
0.350
Why?
Immunoglobulin E
9
2019
50
0.350
Why?
Research Design
3
2018
313
0.350
Why?
Ovarian Neoplasms
1
2010
95
0.340
Why?
Treatment Failure
8
2018
171
0.340
Why?
Alendronate
2
2019
12
0.340
Why?
Genetic Association Studies
1
2009
147
0.340
Why?
Receptors, Adrenergic, beta
2
2006
13
0.340
Why?
Drug Resistance
3
2020
42
0.340
Why?
Chlorofluorocarbons
1
2009
1
0.340
Why?
Bronchoalveolar Lavage Fluid
5
2020
77
0.330
Why?
Aerosol Propellants
1
2009
2
0.330
Why?
Hydrocarbons, Fluorinated
1
2009
5
0.330
Why?
Genotype
12
2020
742
0.330
Why?
Bronchial Hyperreactivity
6
2015
23
0.330
Why?
Cross-Over Studies
6
2019
101
0.330
Why?
Anti-Inflammatory Agents
4
2015
102
0.320
Why?
Microfilament Proteins
2
2006
35
0.320
Why?
Patient Acceptance of Health Care
4
2019
171
0.320
Why?
Inflammation Mediators
2
2010
103
0.310
Why?
Randomized Controlled Trials as Topic
4
2021
511
0.310
Why?
Risk Factors
12
2021
3876
0.310
Why?
Case-Control Studies
10
2019
911
0.300
Why?
Hypersensitivity
1
2007
27
0.290
Why?
Beclomethasone
6
2015
8
0.290
Why?
Peak Expiratory Flow Rate
9
2018
15
0.290
Why?
Interleukin-13
6
2012
33
0.280
Why?
Prospective Studies
9
2019
2274
0.280
Why?
Reproducibility of Results
4
2021
779
0.280
Why?
Clinical Trials as Topic
6
2013
316
0.280
Why?
Patient Education as Topic
1
2009
276
0.280
Why?
Vitamin D Deficiency
3
2018
93
0.280
Why?
Hispanic Americans
3
2020
949
0.270
Why?
Risk Assessment
7
2019
1447
0.270
Why?
Cohort Studies
11
2021
1832
0.270
Why?
Th1 Cells
3
2013
29
0.270
Why?
Dietary Supplements
2
2018
184
0.260
Why?
Animals
8
2017
7694
0.260
Why?
Respiratory Mucosa
2
2021
14
0.260
Why?
Genetic Loci
3
2019
149
0.260
Why?
Arginase
3
2010
9
0.260
Why?
Skin
2
2017
217
0.260
Why?
Pregnadienediols
2
2015
2
0.250
Why?
Paranasal Sinuses
2
2015
6
0.250
Why?
Allergy and Immunology
1
2004
3
0.250
Why?
Breath Tests
6
2020
21
0.250
Why?
Prevalence
5
2019
986
0.240
Why?
Tomography, X-Ray Computed
5
2020
920
0.240
Why?
Patient Selection
2
2021
289
0.230
Why?
Aged, 80 and over
11
2021
4050
0.230
Why?
Prognosis
5
2018
1523
0.230
Why?
Postural Balance
1
2016
180
0.230
Why?
Transforming Growth Factors
1
2003
3
0.220
Why?
Antigenic Modulation
1
2003
2
0.220
Why?
Pesticides
1
2016
202
0.220
Why?
Actins
1
2003
53
0.220
Why?
Anti-Bacterial Agents
3
2018
309
0.220
Why?
Signal Transduction
5
2018
701
0.220
Why?
Transients and Migrants
1
2016
293
0.210
Why?
Haplotypes
4
2010
224
0.210
Why?
Emigrants and Immigrants
1
2016
250
0.210
Why?
Biopsy
4
2017
273
0.210
Why?
Practice Guidelines as Topic
4
2017
410
0.210
Why?
Child, Preschool
8
2019
1281
0.210
Why?
Recurrence
3
2017
266
0.210
Why?
Myofibrils
1
2002
10
0.210
Why?
Receptors, Glucocorticoid
3
2011
8
0.200
Why?
Mucus
1
2021
6
0.200
Why?
Age of Onset
5
2012
100
0.190
Why?
Disease Management
3
2017
131
0.190
Why?
Arginine
2
2012
18
0.190
Why?
Comorbidity
4
2017
572
0.190
Why?
Aging
3
2017
953
0.190
Why?
Iron-Binding Proteins
1
2020
5
0.190
Why?
Social Class
1
2021
89
0.190
Why?
Amino Acids
2
2019
49
0.180
Why?
Age Factors
8
2017
1204
0.180
Why?
Minority Groups
1
2021
76
0.180
Why?
alpha 1-Antitrypsin
1
2020
4
0.180
Why?
Mouth
1
2020
25
0.180
Why?
Progesterone Reductase
1
2020
3
0.180
Why?
Steroid Isomerases
1
2020
3
0.180
Why?
Multienzyme Complexes
1
2020
17
0.180
Why?
Idiopathic Pulmonary Fibrosis
1
2019
6
0.180
Why?
Lung Diseases, Interstitial
1
2019
9
0.180
Why?
Iron
1
2020
117
0.170
Why?
Respiratory Sounds
1
2019
10
0.170
Why?
Muscarinic Antagonists
1
2019
15
0.170
Why?
T-Lymphocyte Subsets
2
2010
26
0.160
Why?
Androstadienes
4
2010
21
0.160
Why?
Emergency Service, Hospital
2
2019
463
0.160
Why?
Corynebacterium
1
2018
1
0.160
Why?
T-Lymphocytes
2
2011
128
0.160
Why?
Moraxella
1
2018
3
0.160
Why?
Aspirin
1
2018
65
0.160
Why?
Sleep
1
2019
93
0.160
Why?
Cluster Analysis
3
2013
131
0.160
Why?
Preoperative Care
1
2019
116
0.160
Why?
Gene Expression
3
2021
345
0.160
Why?
Patient Care Team
1
2019
131
0.160
Why?
Guideline Adherence
1
2019
122
0.160
Why?
Hydroxyurea
1
2018
3
0.160
Why?
Multivariate Analysis
6
2018
696
0.160
Why?
Gonadal Steroid Hormones
1
2018
29
0.160
Why?
Interleukin-4
2
2012
22
0.160
Why?
Natriuretic Peptide, Brain
1
2018
65
0.160
Why?
Registries
1
2019
300
0.150
Why?
Insurance, Health, Reimbursement
1
2017
16
0.150
Why?
Indoleacetic Acids
1
2017
2
0.150
Why?
Shewanella putrefaciens
1
2017
1
0.150
Why?
Laboratories
1
2017
16
0.150
Why?
Gram-Negative Bacterial Infections
1
2017
14
0.150
Why?
Soft Tissue Infections
1
2017
10
0.150
Why?
Pathology
1
2017
19
0.150
Why?
Body Mass Index
6
2018
921
0.150
Why?
Pyridines
1
2017
81
0.150
Why?
Autoimmunity
1
2017
34
0.150
Why?
Hand
1
2017
67
0.150
Why?
Sleep Apnea Syndromes
1
2017
30
0.140
Why?
Membrane Glycoproteins
2
2011
110
0.140
Why?
Ibuprofen
1
2016
4
0.140
Why?
Emphysema
1
2016
7
0.140
Why?
Blood Proteins
1
2016
19
0.140
Why?
Delayed-Action Preparations
1
2016
35
0.140
Why?
Self Care
1
2017
145
0.140
Why?
Acetaminophen
1
2016
20
0.140
Why?
Patient Readmission
1
2017
115
0.140
Why?
Fluocinolone Acetonide
2
2009
7
0.140
Why?
Antibodies, Anti-Idiotypic
2
2006
8
0.140
Why?
Biomedical Research
3
2012
169
0.130
Why?
Medicare
1
2017
206
0.130
Why?
Azithromycin
1
2015
15
0.130
Why?
Respiratory System
2
2007
13
0.130
Why?
Dose-Response Relationship, Drug
5
2019
675
0.130
Why?
Linkage Disequilibrium
6
2012
192
0.130
Why?
Skin Diseases
1
2017
144
0.130
Why?
African Continental Ancestry Group
1
2017
364
0.130
Why?
Secondary Prevention
1
2015
65
0.130
Why?
Outpatients
1
2015
58
0.130
Why?
Bacteria
2
2016
50
0.130
Why?
Peptide Fragments
1
2018
422
0.130
Why?
Palliative Care
1
2015
54
0.120
Why?
Odds Ratio
5
2015
480
0.120
Why?
Predictive Value of Tests
2
2014
877
0.120
Why?
Interleukin-1
2
2005
35
0.120
Why?
Pregnenediones
1
2014
2
0.120
Why?
Uncertainty
1
2014
13
0.120
Why?
Granulocytes
2
2013
17
0.120
Why?
Diagnostic Techniques, Respiratory System
1
2014
1
0.120
Why?
Clarithromycin
2
2010
2
0.120
Why?
Edetic Acid
1
2014
9
0.120
Why?
Serum
1
2014
20
0.120
Why?
Plasma
1
2014
14
0.120
Why?
Zinc Fingers
1
2013
10
0.120
Why?
Tumor Necrosis Factor-alpha
2
2007
213
0.120
Why?
Brain Death
1
2014
30
0.120
Why?
Patient Preference
1
2014
48
0.120
Why?
Quantitative Trait Loci
3
2021
143
0.120
Why?
Tissue and Organ Harvesting
1
2014
38
0.120
Why?
Drug Administration Schedule
6
2015
279
0.120
Why?
Vitamins
1
2014
68
0.110
Why?
Repressor Proteins
1
2013
52
0.110
Why?
Retrospective Studies
7
2019
3514
0.110
Why?
Multifactorial Inheritance
1
2013
21
0.110
Why?
Pulmonary Diffusing Capacity
1
2013
2
0.110
Why?
Kv Channel-Interacting Proteins
1
2013
3
0.110
Why?
Interferon-gamma
4
2010
63
0.110
Why?
Receptors, Tumor Necrosis Factor
2
2003
49
0.110
Why?
Longitudinal Studies
3
2021
786
0.110
Why?
Liver Transplantation
1
2014
179
0.110
Why?
Interleukin-4 Receptor alpha Subunit
1
2012
6
0.110
Why?
Macrolides
1
2012
8
0.110
Why?
Receptors, Interleukin-6
1
2012
18
0.100
Why?
Carrier Proteins
2
2011
141
0.100
Why?
Dinoprostone
3
2006
34
0.100
Why?
RNA, Ribosomal, 16S
3
2018
15
0.100
Why?
Diabetes Mellitus, Type 2
1
2020
1428
0.100
Why?
Chronic Disease
3
2014
406
0.100
Why?
Metered Dose Inhalers
2
2008
5
0.100
Why?
Proteins
1
2012
150
0.100
Why?
Acute Disease
3
2018
255
0.090
Why?
Tobacco Smoke Pollution
1
2011
41
0.090
Why?
Liver
1
2014
486
0.090
Why?
Incidental Findings
1
2010
27
0.090
Why?
Influenza A Virus, H1N1 Subtype
1
2010
49
0.090
Why?
Preferred Provider Organizations
1
2010
2
0.090
Why?
Health Maintenance Organizations
1
2010
14
0.090
Why?
Time Factors
3
2011
2181
0.090
Why?
Insurance Claim Review
1
2010
28
0.090
Why?
Controlled Clinical Trials as Topic
1
2010
11
0.090
Why?
HLA-DQ Antigens
1
2010
9
0.090
Why?
HLA-DR Antigens
1
2010
9
0.090
Why?
DNA Repair Enzymes
1
2010
16
0.090
Why?
Drug Dosage Calculations
1
2010
8
0.090
Why?
Lymphatic Metastasis
1
2010
172
0.090
Why?
Lymph Node Excision
1
2010
92
0.090
Why?
Cross-Sectional Studies
4
2018
1522
0.090
Why?
Drug Synergism
1
2010
71
0.090
Why?
Superoxide Dismutase
2
2011
44
0.090
Why?
Logistic Models
4
2015
788
0.090
Why?
Sample Size
1
2009
39
0.090
Why?
Allergens
2
2016
18
0.090
Why?
Influenza Vaccines
1
2010
79
0.090
Why?
Lymphocyte Activation
2
2010
90
0.090
Why?
DNA-Binding Proteins
1
2010
149
0.080
Why?
Influenza, Human
1
2010
124
0.080
Why?
Patients
1
2009
47
0.080
Why?
Heat-Shock Proteins
1
2009
33
0.080
Why?
Infant
3
2016
1076
0.080
Why?
ROC Curve
3
2017
171
0.080
Why?
Diagnosis, Differential
1
2010
525
0.080
Why?
Cells, Cultured
5
2010
846
0.080
Why?
Safety
1
2008
78
0.080
Why?
Receptors, Leukotriene
1
2008
4
0.080
Why?
Linear Models
3
2018
454
0.080
Why?
Receptors, Muscarinic
1
2008
10
0.080
Why?
Bronchoconstriction
1
2007
3
0.080
Why?
Neutrophil Activation
1
2007
5
0.080
Why?
Airway Resistance
1
2007
5
0.080
Why?
Amino Acid Substitution
1
2007
41
0.080
Why?
North Carolina
2
2017
1520
0.080
Why?
Proportional Hazards Models
2
2019
759
0.070
Why?
Attitude to Health
1
2009
167
0.070
Why?
Apoptosis
3
2006
368
0.070
Why?
Physician-Patient Relations
1
2009
188
0.070
Why?
Rhinitis
1
2007
12
0.070
Why?
Phospholipases A
2
2005
28
0.070
Why?
Sinusitis
1
2007
19
0.070
Why?
Isoproterenol
1
2006
18
0.070
Why?
HSP70 Heat-Shock Proteins
1
2007
26
0.070
Why?
Enzyme-Linked Immunosorbent Assay
2
2010
167
0.070
Why?
Exhalation
2
2020
5
0.070
Why?
Pituitary-Adrenal System
1
2006
24
0.070
Why?
Ocular Hypertension
1
2006
10
0.070
Why?
Total Lung Capacity
2
2019
2
0.070
Why?
Cataract
1
2006
10
0.070
Why?
Hypothalamo-Hypophyseal System
1
2006
34
0.070
Why?
Risk
2
2018
325
0.070
Why?
Bronchoalveolar Lavage
2
2005
16
0.070
Why?
Glaucoma
1
2006
23
0.070
Why?
Cost of Illness
1
2006
70
0.070
Why?
Phosphodiesterase Inhibitors
1
2005
10
0.070
Why?
CpG Islands
1
2005
46
0.070
Why?
Alleles
2
2020
252
0.070
Why?
Oligodeoxyribonucleotides
1
2005
18
0.070
Why?
Asian Continental Ancestry Group
2
2019
111
0.070
Why?
MAP Kinase Signaling System
1
2005
61
0.070
Why?
Tosyl Compounds
1
2005
4
0.060
Why?
Phosphorylation
1
2006
234
0.060
Why?
Respiratory Physiological Phenomena
1
2005
6
0.060
Why?
Trachea
1
2005
55
0.060
Why?
Rhinitis, Allergic, Perennial
1
2005
7
0.060
Why?
Dermatitis, Atopic
1
2007
104
0.060
Why?
Lung Diseases
1
2005
50
0.060
Why?
Pregnancy Complications
1
2006
107
0.060
Why?
Regression Analysis
2
2017
296
0.060
Why?
Neovascularization, Physiologic
1
2005
112
0.060
Why?
Bone Density
1
2006
186
0.060
Why?
Interleukin-2
3
2010
33
0.060
Why?
Genetic Variation
2
2021
247
0.060
Why?
Follow-Up Studies
3
2018
2296
0.060
Why?
Ethnic Groups
1
2007
480
0.060
Why?
Interleukin-5
1
2003
7
0.060
Why?
Leukotriene D4
1
2003
2
0.060
Why?
Endpoint Determination
1
2003
21
0.050
Why?
Patient Compliance
2
2019
227
0.050
Why?
Pregnancy
1
2006
1010
0.050
Why?
Killer Cells, Natural
1
2002
26
0.050
Why?
Methacholine Chloride
3
2007
5
0.050
Why?
Infusions, Parenteral
1
2021
68
0.050
Why?
Geography
1
2021
35
0.050
Why?
Blotting, Western
1
2002
305
0.050
Why?
Algorithms
2
2017
497
0.050
Why?
Membrane Proteins
1
2002
260
0.050
Why?
Cell Culture Techniques
1
2002
176
0.050
Why?
Maximal Midexpiratory Flow Rate
1
2020
2
0.050
Why?
Isoelectric Focusing
1
2020
5
0.050
Why?
Ferritins
1
2020
48
0.050
Why?
TATA Box Binding Protein-Like Proteins
1
2019
1
0.040
Why?
Mucin-5B
1
2019
3
0.040
Why?
Heterozygote
1
2020
57
0.040
Why?
beta Karyopherins
1
2019
7
0.040
Why?
Residual Volume
1
2019
1
0.040
Why?
Androgens
1
2020
34
0.040
Why?
Administration, Oral
2
2014
185
0.040
Why?
Base Sequence
2
2013
257
0.040
Why?
Isoleucine
1
2019
8
0.040
Why?
Tryptophan
1
2019
5
0.040
Why?
Placebos
2
2012
66
0.040
Why?
Valine
1
2019
17
0.040
Why?
Republic of Korea
1
2019
12
0.040
Why?
Leucine
1
2019
24
0.040
Why?
Drug Combinations
1
2019
93
0.040
Why?
Adrenergic beta-Antagonists
1
2019
62
0.040
Why?
Receptors, Tumor Necrosis Factor, Type II
1
2019
9
0.040
Why?
Receptors, Tumor Necrosis Factor, Type I
1
2019
14
0.040
Why?
Metabolomics
1
2019
53
0.040
Why?
National Heart, Lung, and Blood Institute (U.S.)
1
2019
17
0.040
Why?
Fibrinogen
1
2019
43
0.040
Why?
Promoter Regions, Genetic
1
2019
213
0.040
Why?
Sleep Apnea, Obstructive
1
2019
60
0.040
Why?
Skin Tests
2
2010
14
0.040
Why?
Flow Cytometry
2
2010
187
0.040
Why?
Polymerase Chain Reaction
2
2010
190
0.040
Why?
Vitamin D-Binding Protein
1
2018
10
0.040
Why?
Nose
1
2018
13
0.040
Why?
Platelet Aggregation Inhibitors
1
2018
84
0.040
Why?
Puberty
1
2018
10
0.040
Why?
Feasibility Studies
1
2019
294
0.040
Why?
Incidence
2
2016
1207
0.040
Why?
Growth
1
2018
7
0.040
Why?
Mouth Mucosa
1
2018
31
0.040
Why?
Leukotrienes
1
2018
4
0.040
Why?
Current Procedural Terminology
1
2017
4
0.040
Why?
C-Reactive Protein
1
2019
238
0.040
Why?
Inspiratory Capacity
1
2017
3
0.040
Why?
Immunocompetence
1
2017
12
0.040
Why?
Patient Care
1
2017
37
0.040
Why?
Hand Injuries
1
2017
24
0.040
Why?
Foreign Bodies
1
2017
30
0.040
Why?
Specialization
1
2017
32
0.040
Why?
Workflow
1
2017
23
0.040
Why?
Prednisolone
1
2017
11
0.040
Why?
Medication Adherence
1
2019
161
0.040
Why?
Reference Values
2
2011
255
0.040
Why?
Quality of Life
2
2014
915
0.040
Why?
RNA, Bacterial
1
2016
4
0.040
Why?
Disease Susceptibility
1
2017
58
0.040
Why?
Bronchoconstrictor Agents
2
2007
3
0.040
Why?
Cell Line
1
2018
462
0.040
Why?
ABO Blood-Group System
1
2016
20
0.030
Why?
Sex Distribution
1
2017
201
0.030
Why?
Chi-Square Distribution
1
2017
302
0.030
Why?
Fever
1
2016
63
0.030
Why?
Forced Expiratory Flow Rates
1
2015
3
0.030
Why?
Socioeconomic Factors
1
2017
422
0.030
Why?
RNA, Messenger
1
2018
534
0.030
Why?
Drug Resistance, Bacterial
1
2015
42
0.030
Why?
Accidental Falls
1
2017
219
0.030
Why?
Phospholipases A2
2
2005
22
0.030
Why?
Administration, Intranasal
1
2014
33
0.030
Why?
Nutrition Surveys
1
2016
149
0.030
Why?
Triamcinolone
2
2005
13
0.030
Why?
Ionophores
2
2005
5
0.030
Why?
F-Box Proteins
1
2014
4
0.030
Why?
Calcimycin
2
2005
8
0.030
Why?
Tetradecanoylphorbol Acetate
2
2005
13
0.030
Why?
New Jersey
1
2014
11
0.030
Why?
Protease Inhibitors
1
2014
15
0.030
Why?
Combined Modality Therapy
2
2006
567
0.030
Why?
Cell Survival
2
2006
301
0.030
Why?
Pain
1
2016
305
0.030
Why?
Observer Variation
1
2014
109
0.030
Why?
Interferon Regulatory Factor-2
1
2013
5
0.030
Why?
Liver Cirrhosis
1
2014
81
0.030
Why?
Fatty Liver
1
2014
67
0.030
Why?
STAT4 Transcription Factor
1
2013
17
0.030
Why?
Interleukin-12
1
2013
30
0.030
Why?
Single-Blind Method
2
2004
200
0.030
Why?
Nuclear Pore
1
2012
3
0.030
Why?
Cardiovascular Diseases
1
2021
1133
0.030
Why?
Prednisone
1
2012
62
0.030
Why?
Biomarkers, Pharmacological
1
2012
6
0.030
Why?
3' Untranslated Regions
1
2012
25
0.030
Why?
Tissue Donors
1
2014
199
0.030
Why?
Homozygote
1
2012
60
0.030
Why?
Airway Remodeling
1
2011
5
0.030
Why?
Hydrocortisone
2
2002
61
0.030
Why?
Myocytes, Smooth Muscle
1
2012
73
0.030
Why?
Chromosomes, Human, Pair 12
1
2011
9
0.030
Why?
Chromosomes, Human, Pair 4
1
2011
11
0.030
Why?
Chromosomes, Human, Pair 10
1
2011
9
0.030
Why?
Clinical Protocols
1
2011
100
0.020
Why?
Thrombospondins
1
2011
7
0.020
Why?
Leptin
1
2011
69
0.020
Why?
Receptors, Notch
1
2011
17
0.020
Why?
Interleukin-6
1
2012
248
0.020
Why?
National Institutes of Health (U.S.)
1
2010
31
0.020
Why?
Phylogeny
1
2010
56
0.020
Why?
Chlamydophila pneumoniae
1
2010
4
0.020
Why?
Mycoplasma pneumoniae
1
2010
5
0.020
Why?
Hydrogen-Ion Concentration
1
2010
66
0.020
Why?
Receptors, Cell Surface
1
2011
73
0.020
Why?
Lymphocyte Count
1
2010
25
0.020
Why?
Hospitalization
1
2014
465
0.020
Why?
Proto-Oncogene Proteins
1
2011
94
0.020
Why?
Immunophenotyping
1
2010
51
0.020
Why?
Environmental Exposure
1
2011
92
0.020
Why?
Oligonucleotide Array Sequence Analysis
1
2010
163
0.020
Why?
Protein Array Analysis
1
2010
18
0.020
Why?
Sensitivity and Specificity
1
2011
600
0.020
Why?
Discriminant Analysis
1
2009
22
0.020
Why?
Recombinant Proteins
1
2010
258
0.020
Why?
Vaccination
1
2010
137
0.020
Why?
Pilot Projects
1
2010
536
0.020
Why?
Gene Frequency
1
2009
221
0.020
Why?
Biological Availability
1
2008
22
0.020
Why?
Models, Statistical
1
2009
176
0.020
Why?
London
1
2007
3
0.020
Why?
Lung Volume Measurements
1
2007
5
0.020
Why?
Fluorescent Antibody Technique
1
2007
94
0.020
Why?
Motor Activity
1
2010
327
0.020
Why?
Patient Satisfaction
1
2009
245
0.020
Why?
Chromosomes, Human, Pair 6
1
2007
20
0.020
Why?
DNA Primers
1
2007
90
0.020
Why?
Cyclic AMP-Dependent Protein Kinase Type II
1
2006
1
0.020
Why?
Cyclic AMP-Dependent Protein Kinases
1
2006
20
0.020
Why?
Mice
1
2013
2524
0.020
Why?
Hypertension
1
2014
972
0.020
Why?
Sequence Analysis, DNA
1
2006
136
0.020
Why?
Microsomes
1
2005
14
0.020
Why?
Cytosol
1
2005
27
0.020
Why?
Cyclooxygenase 1
1
2005
23
0.020
Why?
Mitogen-Activated Protein Kinase 1
1
2005
37
0.020
Why?
Mitogen-Activated Protein Kinase 3
1
2005
44
0.020
Why?
Protein Kinases
1
2005
27
0.020
Why?
Prostaglandin-Endoperoxide Synthases
1
2005
32
0.020
Why?
Protein Kinase C
1
2005
32
0.020
Why?
Oxytocics
1
2005
14
0.020
Why?
Carcinogens
1
2005
36
0.020
Why?
p38 Mitogen-Activated Protein Kinases
1
2005
37
0.020
Why?
Cyclooxygenase 2
1
2005
46
0.020
Why?
Lupus Erythematosus, Systemic
1
2006
148
0.020
Why?
Glutathione Peroxidase
1
2005
8
0.020
Why?
NF-kappa B
1
2005
82
0.020
Why?
Antigens, CD
1
2005
105
0.020
Why?
Cell Count
1
2005
52
0.020
Why?
Glutathione
1
2005
45
0.020
Why?
Delivery of Health Care
1
2007
161
0.020
Why?
Enzyme Inhibitors
1
2005
176
0.020
Why?
CD8-Positive T-Lymphocytes
1
2005
95
0.020
Why?
Periodicals as Topic
1
2005
101
0.010
Why?
Oxidative Stress
1
2005
230
0.010
Why?
BH3 Interacting Domain Death Agonist Protein
1
2003
2
0.010
Why?
Caspase 9
1
2003
11
0.010
Why?
Caspase 8
1
2003
14
0.010
Why?
Caspases
1
2003
42
0.010
Why?
Immune Sera
1
2002
10
0.010
Why?
Tumor Necrosis Factor Decoy Receptors
1
2002
5
0.010
Why?
Receptors, TNF-Related Apoptosis-Inducing Ligand
1
2002
8
0.010
Why?
Solubility
1
2002
38
0.010
Why?
TNF-Related Apoptosis-Inducing Ligand
1
2002
25
0.010
Why?
Apoptosis Regulatory Proteins
1
2002
43
0.010
Why?
Survival Rate
1
2005
894
0.010
Why?
Lymphocyte Subsets
1
2002
7
0.010
Why?
Probability
1
2002
160
0.010
Why?
Cell Division
1
2002
98
0.010
Why?
Cell Movement
1
2002
171
0.010
Why?
Infant, Newborn
1
2002
681
0.010
Why?
Peters's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (534)
Explore
_
Co-Authors (16)
Explore
_
Similar People (54)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_